IVERIC BIO INC's ticker is ISEE and the CUSIP is 46583P102. A total of 229 filers reported holding IVERIC BIO INC in Q4 2022. The put-call ratio across all filers is 0.75 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $22,042,542 | +61.3% | 905,982 | +41.9% | 1.41% | +73.9% |
| Q4 2022 | $13,668,101 | -7.2% | 638,398 | -22.2% | 0.81% | -5.4% |
| Q3 2022 | $14,723,000 | +134.4% | 820,665 | +25.7% | 0.86% | +63.9% |
| Q2 2022 | $6,282,000 | -63.4% | 653,047 | -36.1% | 0.52% | -59.9% |
| Q1 2022 | $17,187,000 | +28.7% | 1,021,211 | +27.8% | 1.30% | +67.2% |
| Q4 2021 | $13,356,000 | +130.1% | 798,789 | +123.5% | 0.78% | +126.7% |
| Q3 2021 | $5,804,000 | – | 357,400 | – | 0.34% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TCG Crossover Management, LLC | 5,141,118 | $110,071,336 | 19.43% |
| Deep Track Capital, LP | 7,878,119 | $168,670,528 | 7.08% |
| Soleus Capital Management, L.P. | 2,114,728 | $45,276,326 | 6.50% |
| MPM BioImpact LLC | 1,059,688 | $22,687,920 | 5.89% |
| Finepoint Capital LP | 707,600 | $15,150 | 4.90% |
| ACUTA CAPITAL PARTNERS, LLC | 360,500 | $7,718,305 | 4.75% |
| Octagon Capital Advisors LP | 1,278,000 | $27,361,980 | 4.26% |
| Artia Global Partners LP | 504,615 | $10,803,807 | 4.12% |
| Ghost Tree Capital, LLC | 450,000 | $9,635,000 | 4.11% |
| Redmile Group, LLC | 4,502,111 | $96,390,197 | 3.94% |